Home | Recruitment | News & Events | Customer Support | Contact Us
Reagents
NEW SEROLOGY (ToRCH) PROGRAMME

View Brochure:

RIQAS Infectious Diseases
Enrolment document
Method questionnaire

The RIQAS ToRCH quarterly EQA programme is designed to monitor the performance of 12 infectious diseases that can lead to congenital abnormalities.

  • Liquid ready to use samples for ease of use and convenience
  • 100% human plasma mirrors the performance of patient samples

Cat no:

RQ9152

Vial size:

5 x 1ml (samples shipped 4 times per year)

Frequency:

Quarterly reporting (1 x 12 month cycle), Qualitative results only

Cycle Start Date: 25 June 2012 (Cycle will run from June 2012 to March 2013)

Parameters:

Anti-Toxoplasma IgG
Anti-Toxoplasma IgM
Anti-Rubella IgG
Anti-Rubella IgM
Anti-CMV IgG
Anti-CMV IgM
Anti-HSV1 IgG
Anti-HSV1 IgM
Anti-HSV2 IgG
Anti-HSV2 IgM
Anti-HSV-1&2 IgG (combined)
Anti-HSV-1&2 IgM (combined)


Please contact marketing@randox.com if you would like to participate

Products

Toxicology

Contract Manufacturing

Randox Engineering
Other Randox Websites

Randox Food Diagnostics
Randox Toxicology
Randox Life Sciences
Randox Health Checks
Randox Online Store
Randox Pharma Services
Randox Testing Services
Drugs of Abuse Testing
RIQAS
Lab Test Blog


Follow us on facebook Follow us on twitter Linked In You Tube

Accreditation